Fu G - Search Results

1

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy.

Diaz Osterman CJ, Ozmadenci D, Kleinschmidt EG, Taylor KN, Barrie AM, Jiang S, Bean LM, Sulzmaier FJ, Jean C, Tancioni I, Anderson K, Uryu S, Cordasco EA, Li J, Chen XL, Fu G, Ojalill M, Rappu P, Heino J, Mark AM, Xu G, Fisch KM, Kolev VN, Weaver DT, Pachter JA, Győrffy B, McHale MT, Connolly DC, Molinolo A, Stupack DG, Schlaepfer DD. Diaz Osterman CJ, et al. Among authors: fu g. Elife. 2019 Sep 3;8:e47327. doi: 10.7554/eLife.47327. Elife. 2019. PMID: 31478830 Free PMC article.

2

Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats.

Liu RF, Fu G, Li J, Yang YF, Wang XG, Bai PD, Chen YD. Liu RF, et al. Among authors: fu g. Exp Ther Med. 2018 Mar;15(3):2703-2710. doi: 10.3892/etm.2018.5772. Epub 2018 Jan 19. Exp Ther Med. 2018. PMID: 29456672 Free PMC article.

3

Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy.

Shan W, Zheng H, Fu G, Liu C, Li Z, Ye Y, Zhao J, Xu D, Sun L, Wang X, Chen XL, Bi S, Ren L, Fu G. Shan W, et al. Among authors: fu g. Nano Lett. 2019 Mar 13;19(3):1719-1727. doi: 10.1021/acs.nanolett.8b04722. Epub 2019 Feb 11. Nano Lett. 2019. PMID: 30724087

4

Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway.

Yang Q, Chen K, Zhang L, Feng L, Fu G, Jiang S, Bi S, Lin C, Zhou Y, Zhao H, Chen XL, Fu G, Xu B. Yang Q, et al. Among authors: fu g. Cancer Lett. 2019 Oct 1;461:31-43. doi: 10.1016/j.canlet.2019.07.003. Epub 2019 Jul 10. Cancer Lett. 2019. PMID: 31301319

5

A Carrier Strategy for Mass Cytometry Analysis of Small Numbers of Cells.

Jia X, Zhou X, Zheng H, Jiang S, Weng J, Huang L, Du Z, Xiao C, Zhang L, Chen XL, Fu G. Jia X, et al. Among authors: fu g. Methods Mol Biol. 2020;2111:21-33. doi: 10.1007/978-1-0716-0266-9_2. Methods Mol Biol. 2020. PMID: 31933195

6

Themis is indispensable for IL-2 and IL-15 signaling in T cells.

Liu Y, Cong Y, Niu Y, Yuan Y, Tan F, Lai Q, Hu Y, Hou B, Li J, Lin C, Zheng H, Dong J, Tang J, Chen Q, Brzostek J, Zhang X, Chen XL, Wang HR, Gascoigne NRJ, Xu B, Lin SH, Fu G. Liu Y, et al. Among authors: fu g. Sci Signal. 2022 Feb 15;15(721):eabi9983. doi: 10.1126/scisignal.abi9983. Epub 2022 Feb 15. Sci Signal. 2022. PMID: 35167340

7

Themis suppresses the effector function of CD8⁺ T cells in acute viral infection.

Tang J, Jia X, Li J, Dong J, Wang J, Li W, Zhu Y, Hu Y, Hou B, Lin C, Cong Y, Ren T, Yan C, Yang H, Lai Q, Zheng H, Bao Y, Gautam N, Wang HR, Xu B, Chen XL, Li Q, Gascoigne NRJ, Fu G. Tang J, et al. Among authors: fu g. Cell Mol Immunol. 2023 May;20(5):512-524. doi: 10.1038/s41423-023-00997-z. Epub 2023 Mar 28. Cell Mol Immunol. 2023. PMID: 36977779 Free PMC article.

8

SHP-1 Regulates CD8+ T Cell Effector Function but Plays a Subtle Role with SHP-2 in T Cell Exhaustion Due to a Stage-Specific Nonredundant Functional Relay.

Hou B, Hu Y, Zhu Y, Wang X, Li W, Tang J, Jia X, Wang J, Cong Y, Quan M, Yang H, Zheng H, Bao Y, Chen XL, Wang HR, Xu B, Gascoigne NRJ, Fu G. Hou B, et al. Among authors: fu g. J Immunol. 2024 Feb 1;212(3):397-409. doi: 10.4049/jimmunol.2300462. J Immunol. 2024. PMID: 38088801

9

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.

Huang J, Alexey S, Li J, Jones T, Grande G, Douthit L, Xie J, Chen D, Wu X, Michael M, Xiao C, Zhao J, Xie X, Xie J, Chen XL, Fu G, Alexander G, Tzeng CM. Huang J, et al. Among authors: fu g. Leukemia. 2019 Sep;33(9):2315-2319. doi: 10.1038/s41375-019-0455-3. Epub 2019 Apr 8. Leukemia. 2019. PMID: 30962578 No abstract available.

10

Correction: Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.

Huang J, Alexey S, Li J, Jones T, Grande G, Douthit L, Xie J, Chen D, Wu X, Michael M, Xiao C, Zhao J, Xie X, Xie J, Chen XL, Fu G, Alexander G, Tzeng CM. Huang J, et al. Among authors: fu g. Leukemia. 2019 Sep;33(9):2341. doi: 10.1038/s41375-019-0484-y. Leukemia. 2019. PMID: 31097784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,255 results

Search Page